Liquidia

YTD

ALL

Trade Liquidia 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LQDA

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

CEO

Roger A. Jeffs

CEORoger A. Jeffs

Employees

157

Employees157

Headquarters

Morrisville, North Carolina

HeadquartersMorrisville, North Carolina

Founded

2004

Founded2004

Employees

157

Employees157

LQDA Key Statistics

Market cap

3.84B

Market cap3.84B

Price-Earnings ratio

-29.64

Price-Earnings ratio-29.64

Dividend yield

—

Dividend yield—

Average volume

2.05M

Average volume2.05M

High today

$44.85

High today$44.85

Low today

$42.20

Low today$42.20

Open price

$42.34

Open price$42.34

Volume

1.26M

Volume1.26M

52 Week high

$44.85

52 Week high$44.85

52 Week low

$11.26

52 Week low$11.26

Stock Snapshot

As of today, Liquidia(LQDA) shares are valued at $44.15. The company's market cap stands at 3.84B, with a P/E ratio of -29.64.

On 2026-02-02, Liquidia(LQDA) stock traded between a low of $42.20 and a high of $44.85. Shares are currently priced at $44.15, which is +4.6% above the low and -1.6% below the high.

Liquidia(LQDA) shares are trading with a volume of 1.26M, against a daily average of 2.05M.

During the past year, Liquidia(LQDA) stock moved between $11.26 at its lowest and $44.85 at its peak.

LQDA News

Nasdaq 3d

Liquidia Reaches Analyst Target Price

In recent trading, shares of Liquidia Corp (Symbol: LQDA) have crossed above the average analyst 12-month target price of $43.00, changing hands for $43.06/shar...

Simply Wall St 4d

Assessing Liquidia Valuation After New Pulmonary Hypertension Data Plans For PVRI 2026

Liquidia (LQDA) recently announced it will share interim and open label clinical data for LIQ861, branded as YUTREPIA, and investigational L606 at the PVRI 2026...

Simply Wall St 6d

Is Liquidia Quietly Reframing Its Pulmonary Hypertension Strategy With New Inhaled Data?

Liquidia recently announced it will present three posters at the 2026 PVRI Annual Congress in Dublin, sharing clinical data on LIQ861 (YUTREPIA) and its investi...

Analyst ratings

89%

of 9 ratings

Buy

88.9%

Hold

Sell

11.1%

People also own

Based on the portfolios of people who own LQDA. This list is generated using Robinhood data, and it’s not a recommendation.

Rocket Lab Corporation

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.